Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Communicable Diseases Intelligence (2018)|April 15, 2019
Arboviral diseases and malaria in Australia, 2014–15: Annual report of the National Arbovirus and Malaria Advisory CommitteeKatrina Knope, Stephen L Doggett, Cassie C Jansen, et al.International Journal of Molecular Sciences|January 21, 2022
Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 InfectionBang M Tran, Samantha L Grimley, Julie L McAuley, et al.Cell Death & Disease|June 24, 2021
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical modelsMichelle P Clark, Thao Huynh, Shringar Rao, et al.Analytical Chemistry|August 6, 2025
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like ParticlesAnkit Dodla, Magdalena Giergiel, Aaron Mclean, et al.Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virusGregor Ebert, Simon Preston, Cody Allison, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2010
Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infectionJohn J Miles, Duangtawan Thammanichanond, Sarah Moneer, et al.The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.Annals of Internal Medicine|April 5, 2013
GeoSentinel surveillance of illness in returned travelers, 2007-2011Karin Leder, Joseph Torresi, Michael D Libman, et al.Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.Frontiers in Microbiology|June 23, 2023
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidatesSimon Collett, Linda Earnest, Julio Carrera Montoya, et al.Pageof 16